Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer
In Vivo · 2026-05 · 40 (3) · 1768-1775
DOI: 10.21873/invivo.14329 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, online erschienen am 28.04.2026. Verfasst von Dirk Rades und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de. Hauptthemen laut MEDLINE: Breast Neoplasms, Mobile Applications, Skin, Radiotherapy. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
- Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany.
- Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
Zitieren
APA
Rades, D., Dziggel, L., Narvaez-Wolf, C. A., Radtke, M., Staackmann, C., Holm, H. S., & Kristiansen, C. (2026). Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer. In Vivo, 40(3), 1768-1775. https://doi.org/10.21873/invivo.14329
Vancouver
Rades D, Dziggel L, Narvaez-Wolf CA, Radtke M, Staackmann C, Holm HS, et al. Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer. In Vivo. 2026;40(3):1768-1775. doi:10.21873/invivo.14329
BibTeX
@article{Rades2026,
author = {Rades, Dirk and Dziggel, Liesa and Narvaez-Wolf, Carlos A and Radtke, Maike and Staackmann, Christian and Holm, Hanne Spangsberg and Kristiansen, Charlotte},
title = {Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer},
journal = {In Vivo},
year = {2026},
volume = {40},
number = {3},
pages = {1768--1775},
doi = {10.21873/invivo.14329}
}
EUVIMED